ArticleBioMed research international2018

Real-World Results of Aflibercept versus Ranibizumab for the Treatment of Exudative AMD Using a Fixed Regimen.

Joana Providência et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.